Nifuroxazide ameliorates lipid and glucose metabolism in palmitate-induced HepG2 cells

Inflammation constitutes an important component of non-alcoholic fatty liver disease. STAT3 is a direct target of inflammatory cytokines, but also mediates glycolipid metabolism in the liver. As a potent inhibitor of STAT3, the effect of Nifuroxazide (Nifu) on glycolipid metabolism in liver has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing-Yi, Zhang, Yi-Chen, Song, Li-Ni, Zhang, Lin, Yang, Fang-Yuan, Zhu, Xiao-Rong, Cheng, Zhi-Qiang, Cao, Xi, Yang, Jin-Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076084/
https://www.ncbi.nlm.nih.gov/pubmed/35540668
http://dx.doi.org/10.1039/c9ra06527j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076084/
https://www.ncbi.nlm.nih.gov/pubmed/35540668
http://dx.doi.org/10.1039/c9ra06527j

Ejemplares similares